台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-群益金鼎-東大 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-東大 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/16184.0000.0084.0012710.37%
2025/01/13285.3000.0083.9022690.74%
2025/01/10187.6000.0085.8012590.39%
2025/01/09288.8000.0088.5022510.79%
2025/01/0600.00191.2090.70-1246-0.41%
2025/01/02189.5000.0090.2012480.40%
2024/12/3100.00290.8090.60-2247-0.81%
2024/12/24289.6000.0089.9022480.80%
2024/12/1700.00290.3090.20-2243-0.82%
2024/12/1600.00789.9790.30-7242-2.89%
2024/12/13590.8000.0090.6052382.09%
2024/12/12592.5000.0092.5052332.14%
2024/12/11394.0000.0094.0032291.31%
2024/12/06097.0000.0097.0002200.00%
2024/12/05097.70297.8097.40-2218-0.91%
2024/12/04097.6000.0097.8002160.00%
2024/12/03298.10397.5397.80-1216-0.46%
2024/12/02096.7000.0096.1002040.00%
2024/11/26396.0000.0095.5031931.55%
2024/11/2500.00197.4097.60-1187-0.53%
2024/11/21397.13397.1798.0001780.00%
2024/11/20198.504.397.9897.80-3.3172-1.92%
2024/11/18895.5400.0096.0081515.27%
2024/11/1400.00194.9094.90-1142-0.70%
2024/11/12194.30194.0094.3001230.00%
2024/11/1100.002.494.1193.30-2.4112-2.14%
2024/11/08189.9000.0090.401951.05%
2024/10/302.489.5500.0089.602.41142.09%
2024/09/2700.00089.3089.8001350.00%
2024/09/1200.002.187.1887.50-2.1156-1.36%
2024/09/0500.0011.187.7086.50-11.1160-6.93%
2024/08/0900.00190.9091.00-1204-0.49%
2024/08/0200.00191.3091.00-1205-0.49%
2024/07/3000.00190.9091.00-1204-0.49%
2024/07/18192.60192.5092.7001990.00%
2024/07/1500.00192.8092.80-1202-0.49%
2024/07/12191.7000.0091.8012000.50%
2024/07/10191.4000.0091.6012040.49%
2024/07/02190.6000.0091.2012060.48%
2024/06/25189.4000.0089.5012040.49%
2024/06/21190.4000.0090.3012060.49%
2024/06/20190.5000.0090.2012060.48%
2024/06/17190.600.590.9590.800.52080.24%
2024/05/270.292.9500.0093.100.22340.09%
2024/05/200.292.9000.0093.400.22330.09%
2024/05/170.193.5000.0093.900.12300.04%
2024/04/190.186.7000.0086.400.12540.05%
2024/04/1600.00187.3087.40-1249-0.40%
2024/03/261.287.5500.0087.201.22600.46%
2024/03/13187.7000.0087.9012850.35%
2024/03/12189.0000.0089.0012780.36%
2024/03/08191.40193.1090.4002730.00%
2024/03/05191.2000.0090.9012740.36%
2024/03/01191.6000.0091.4012740.36%
2024/02/22191.3000.0091.3012830.35%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章